A recent open-label trial published in The Journal of Alzheimer's Disease and conducted by a team of Israeli researchers from the Israel and Sackler Faculty of Medicine at Tel-Aviv University has determined cannabis extracts containing THC help treat the symptoms associated with dementia and Alzheimer's disease. The team examined the use of THC treatments on 11 patients with Alzheimer's disease over the course of four weeks. After the treatments, the team recorded a significant reduction in the Clinical Global Impression (CGI) scale and in behavioral and psychological symptoms of dementia like agitation, aggression, irritability, apathy, delusions, and sleep. Because the trial was open-label, both researchers and patients were aware of their medical cannabis with THC without the possibility of receiving a placebo. The researchers stated, “Adding [medical cannabis oil] to [Alzheimer’s disease] patients’ pharmacotherapy is safe and a promising treatment option.”
This information adds to a growing list of clinical trials suggesting that cannabis could have beneficial implications for the treatment of Alzheimer's disease. This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer. You can also access the study here.